Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM

Author:
  • Daniel Agardh
  • L K Gaur
  • Elisabet Agardh
  • Mona Landin-Olsson
  • Carl-David Agardh
  • Åke Lernmark
Publishing year: 1996
Language: English
Pages: 1313-1317
Publication/Series: Diabetologia
Volume: 39
Issue: 11
Document type: Journal article
Publisher: Springer

Abstract english

Some insulin-dependent diabetic (IDDM) patients develop severe forms of retinopathy. Putative risk factors such as hypertension, poor metabolic control, nephropathy and growth hormone levels do not fully explain the progress of retinopathy in these patients. It has been discussed whether there is a genetic marker, since some diabetic patients without any known predisposing risk factors develop severe retinopathy and others do not. In the present study, HLA-DR and DQ were compared in two patient groups with IDDM. One group consisted of patients with early-onset diabetes, with severe non-proliferative or proliferative retinopathy; the other group had no or only mild signs of retinopathy. High resolution HLA typing was carried out by polymerase chain reaction (PCR) and hybridization with allele specific probes. Alleles on the DR3-DQ2 haplotype, DRB1*0301, DQA1*0501 and DQB1*0201, were more frequent in patients with severe retinopathy. A difference was seen when combining certain alleles in the genotypes of DQA1*03/0501 (p > 0.05) and DQB1*0201/0302 (p < 0.01). The findings of the present study suggest that DQB1*0201/0302 is the strongest genetic marker for severe retinopathy and DRB1*0301/0401 only has a secondary influence when combined with this genotype. It seems as if IDDM patients who are positive for the genotype DR3-DQ2/DR4-DQ8 (DRB1*0301-DQA1*0501-DQB1*0201/DRB1*0401 -DQA1*03-DQB1*0302) are at greater risk of developing severe retinopathy.

Keywords

  • Endocrinology and Diabetes
  • Severe retinopathy
  • insulin-dependent diabetes mellitus
  • HLA-DR
  • HLA-DQ
  • allele
  • haplotype
  • genotype

Other

Published
  • Paediatric Endocrinology
  • Diabetes and Celiac Unit
  • ISSN: 1432-0428
E-mail: ake [dot] lernmark [at] med [dot] lu [dot] se

Principal investigator

Diabetes and Celiac Unit

+46 40 39 19 01

+46 70 616 47 79

60:11:015

Jan Waldenströms gata 35, Malmö

33

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00